Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Drug Design, Development and Therapy|January 17, 2024
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence StudyMarco Finocchietti, Maria Lucia Marino, Alessandro C Rosa, et al.
Frontiers in Public Health|March 3, 2023
Impact of COVID-19 pandemic on outpatient visit volume in cancer patients: Results of COMETA multicenter retrospective observational studyVincenza Frisardi, Oronzo Brunetti, Vincenza Abbinante, et al.
Plos One|January 2, 2024
Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT studyArianna Bellini, Marco Finocchietti, Alessandro Cesare Rosa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Natalizumab: a country-based surveillance programGian Luigi Mancardi, Maria Pia Amato, Roberto D'Alessandro, et al.
Neuron|January 22, 2021
Common fronto-temporal effective connectivity in humans and monkeysFrancesca Rocchi, Hiroyuki Oya, Fabien Balezeau, et al.
BMC Nephrology|October 27, 2023
Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)Alessandro C Rosa, Marco Finocchietti, Nera Agabiti, et al.
Frontiers in Pharmacology|October 3, 2022
An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT projectValeria Belleudi, Alessandro C Rosa, Marco Finocchietti, et al.
Frontiers in Transplantation|July 12, 2024
Temporal and spatial variability of immunosuppressive therapies in transplant patients: An observational study in ItalyMaria Lucia Marino, Alessandro C Rosa, Marco Finocchietti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 3, 2009
The pharmacovigilance program on natalizumab in Italy: 2 years of experienceG Tedeschi, M P Amato, R D'Alessandro, et al.
Vaccine|June 12, 2026
Safety of influenza vaccine during the vaccination campaign 2021/2022 in Italy: a self-controlled case series studyStefania Spila-Alegiani, Marco Massari, Maria Cutillo, et al.
Pageof 12